27.7 C
Vientiane
Wednesday, July 23, 2025
spot_img
Home Blog Page 2081

OctaFX sponsors exam fees for ‘Ideas Academy’ students

KUALA LUMPUR, MALAYSIA – Media OutReach – 28 March 2023 – The international broker OctaFX has sponsored the Cambridge IGCSE curriculum exam fees for students in Malaysia under the tutelage of the Ideas Academy—a renowned institution, bend on proliferating and extending a high quality international school structure. Their straightforward mission is ‘to unlock human potential when it matters most’.

Since OctaFX’s mission statement is remarkably similar, it was only a matter of time before the fintech company would reach out to collaborate and support.

It is all the more gratifying that all the involved students were able to pass the exams past December. The graduation ceremony took place on 24 February 2023—with OctaFX being invited, as well.

The OctaFX webinar speaker and expert Gero Azrul held a motivational speech at the graduation, after which presents were given to the children. On this occasion, the broker made a charitable donation by providing new IT equipment to the teaching staff.

Ideas Academy’s marketing executive, Ms. Simran, had this to say: “This is absolutely amazing for our school and, needless to say, for our students. We cannot thank OctaFX enough, and our entire team is excited about putting the much appreciated equipment to good use!”

The Kuala Lumpur-based Ideas Academy has been active in the field of improving and raising the standard of education since 2012. They specialise in working with underprivileged children, including those with refugee background.

The people driving Ideas Academy forward believe in ‘Education for All’. It is their mission to ensure that every child between 12 and 18 years of age gains a strong secondary educational foundation. By safeguarding this, they encourage them to become confident, responsible, proactive, and compassionate adults. Ideas Academy is determined to be a force for high quality, affordable virtual education— combined with physical classes for students in Kuala Lumpur.

This has been the first joint initiative between OctaFX and Ideas Academy, but not the last—both entities are in the talks to continue and deepen their relationship for more projects to come.

Hashtag: #OctaFX

The issuer is solely responsible for the content of this announcement.

About OctaFX

is an international broker that has been providing online trading services worldwide since 2011. The company is involved in a comprehensive network of charity and humanitarian initiatives, including the improvement of educational infrastructure and short-notice relief projects supporting local communities.

Xapo Bank Becomes The First Fully Licensed Bank To Enable USDC Deposits and Withdrawals

Xapo Banks marks a watershed moment for digital asset innovation by enabling members to bypass costly and time-consuming SWIFT payments and deposit and withdraw via USDC instead.

BANGKOK, THAILAND – Media OutReach – 28 March 2023 – Xapo Bank, a leading Bitcoin custodian and licensed private bank, has collaborated with Circle, a global financial technology company helping money move at internet speed, to become the first licensed bank in the world to integrate USDC payment rails as an alternative to SWIFT.

Rectangle 1146.png

USDC is a digital dollar, also known as a stablecoin, that provides a faster and more efficient way to send and receive money around the globe, 24/7, including weekends, in under an hour. By adding outrails to its existing USDC onramps, Xapo Bank enables members to bypass costly and time-consuming SWIFT payments and instead deposit and withdraw with no fees charged by Xapo Bank.

The bank is offering a 1:1 conversion rate from USDC to USD. All USDC deposits at Xapo Bank are automatically converted to USD, meaning members can benefit from a 4.1% annual interest rate return on deposits.

A fully licensed and regulated bank, Xapo Bank is a member of the Gibraltar Deposit Guarantee Scheme (GDGS) and guarantees its members’ USD deposits up to *$100,000 USD equivalent. Ensuring member protection, Xapo Bank does not stake any crypto deposits or have any exposure to surrounding crypto markets as all deposits are automatically converted to USD held by the bank.

Unlike traditional banks, Xapo Bank does not lend and therefore does not rely on fractional reserve banking to make money as its core business model. Instead, Xapo Bank has all its customers’ funds in reserve and invests in short-term liquid assets to pass the interest earned to its customers.

Seamus Rocca, CEO of Xapo Bank, said: “Xapo Bank’s USDC payment rails mark a watershed moment in financial history, combining the speed and cost efficiency of the digital dollar with the security guarantees of a licensed private bank. Enabling auto-converted USDC deposits and withdrawals at Xapo Bank gives crypto members a safe haven for their savings. Running 24/7, including weekends, we eliminate the anxiety of keeping your money in exchanges and the hassle of expensive offramps into traditional banks.”

“Xapo Bank was built to protect members’ savings. Unlike many traditional banks, we do not offer customer loans; all of our customers’ money is held dollar for dollar on our balance sheet. It is invested in very short-dated, highly credit-rated money market instruments and short-term bonds. We pass that benefit to our members through a 4.1% interest rate, paid daily.”

“We charge our members an honest membership fee of $150 USD that helps us recover our overheads and means we don’t have to rely on paying almost no interest to our members or use hidden fees to make money. We give the benefit of more than 80% of the yield we generate back to our members.”

Xapo Bank is constantly striving to grow its payment rails options, offering members additional currency choices managed with the security of a fully-regulated bank. The USDC news comes after last week’s announcement that Xapo Bank had integrated with the Faster Payment System (FPS) to activate support for GBP settlement for account deposits and withdrawals. Earlier this month, the bank also announced an integration with Bitcoin’s Lightning Network, in collaboration with Lightspark.

*Xapo offers 4.1% interest on US dollar deposits, which are protected by the GDGS up to €100,000 EUR (i.e. circa $106,673 at current exchange rates).

To learn more about Xapo Bank, visit: https://www.xapo.com/

Hashtag: #XapoBank



The issuer is solely responsible for the content of this announcement.

About Xapo Bank

Bank is a leading Bitcoin custodian and a fully licensed private bank. Founded in 2013, Xapo became one of the most trusted Bitcoin custodians in the industry, providing users with a secure platform to store and transact with their cryptocurrency. Evolving into Xapo Bank, it became the first crypto company in the world to obtain a and has since expanded its offerings to include Savings accounts. It has future ambitions of offering Wealth Management and a full suite of private banking services like secured lending and asset protection among its future ambitions. With this expansion, Xapo is poised to become one of the leading private banks in the world, offering clients a level of security, privacy, and flexibility that is unmatched in the traditional banking industry.

About Circle

Circle is a global financial technology firm that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. Circle is powering always-on internet-native commerce, payments, and custody and is the issuer of USDC and EUROC. Circle’s open and programmable platform and APIs make it easy for organisations both large and small to run their internet-scale business, whether it is managing their internal treasury, making international payments, or automating supply chains. Learn more at

About Faster Payments

The Faster Payments Service (FPS) is a secure payments network that allows banks in the UK to send payments faster. It works by allowing banks on the network to electronically and securely transfer money between each other, with near-instant availability of funds. It is available 24 hours a day, 365 days a year.

FPS’s benefits include faster processing time for payments, reduced costs and increased customer satisfaction.

About Lightning Network

The Lightning Network is a decentralised network on the Bitcoin blockchain that enables instant, low-cost payments across a network of participants. The Lightning protocol makes use of the security and liquidity of the Bitcoin network to create a secure network of participants who are able to transact bitcoin at high volume and high speed with low cost and instant settlement.

Avery Dennison reaffirms its sustainability commitments with adoption of the Carbon Trust footprint solution

Supply chain transparency is critical to driving continuous improvement in environmental impact measurement and reporting for the labelling and packaging industry

SINGAPORE – Media OutReach – 28 March 2023 – Global materials science leader, Avery Dennison Corporation (NYSE:AVY), is transitioning to a bespoke carbon footprint tool created in collaboration with the Carbon Trust to continue its drive towards transparency and continuous improvement in environmental impact measurement and reporting on its products.

Carbon Trust main image.jpg

The Carbon Trust will present information and insights with the use of verified primary data from Avery Dennison’s suppliers and operations to accurately measure the impact of current and future products. It will also enable Avery Dennison to advance efforts in meeting its 2030 sustainability goals and provide more certainty for guidance on customer product selections and new product development.

The Carbon Trust is intended to provide information on the carbon and water footprint specific to Avery Dennison’s label products. With key learnings and takeaways from the tool’s initial implementation, it will progressively broaden its data with additional product information availability.

“As a company, we’ve monitored and assessed the sustainability of our products for the past 10 years, and this is another important step forward in our goal to provide the most accurate information to our customers,” says Claudia Mariconda, Global Director Sustainability, Materials Group, Avery Dennison. “By implementing the Carbon Trust tool, we facilitate further transparency and offer customers a more trustworthy assessment of our label products’ impacts.”

The Carbon Trust is a global climate consultancy driven by the mission to accelerate the move to a decarbonized future. It has been pioneering decarbonization for more than 20 years for businesses, governments, and organisations around the world. Drawing on a network of over 300 experts internationally, the Carbon Trust guides organizations through their journey to Net Zero.

Hashtag: #AveryDennison

The issuer is solely responsible for the content of this announcement.

About Avery Dennison

Avery Dennison Corporation (NYSE: AVY) is a global materials science and digital identification solutions company that provides branding and information labelling solutions, including pressure-sensitive materials, radio-frequency identification (RFID) inlays and tags, and a variety of converted products and solutions. The company designs and manufactures a wide range of labelling and functional materials that enhance branded packaging, carry or display information that connects the physical and the digital, and improve customers’ product performance. The company serves an array of industries worldwide, including home and personal care, apparel, e-commerce, logistics, food and grocery, pharmaceuticals and automotive. The company employs approximately 36,000 employees in more than 50 countries. Reported sales in 2022 were $9.0 billion. Learn more at .

Reckitt’s brand Dettol further collaborates with the Hong Kong Rugby Union to Support the 2023 Cathay/HSBC Hong Kong Sevens as Official Hygiene Partner

  • Safeguarding the health of up to 40,000 spectators at the first mask-off major sports event at Hong Kong Stadium since the pandemic
  • Setting up hand sanitiser stations at 75 key locations across the Stadium to provide convenient access to the spectators and VIPs on hygiene protection so that everyone can enjoy the exciting games between 28 international teams to the fullest

HONG KONG SAR – Media OutReach – 28 March 2023 – Since 2021, Reckitt’s brand Dettol has collaborated closely with the Hong Kong Rugby Union to support world-class sporting events, and the brand is proud to be the Official Hygiene Partner of the Cathay/HSBC Hong Kong Sevens again this year. Although Hong Kong is moving into a new post-pandemic phase, the general public remain conscious of hygiene awareness. Dettol will help implement enhanced hygiene protocols for spectators to support this first mask-off rugby international tournament in Hong Kong since the pandemic. With no social distancing measures in effect, the tournament will see 16 men’s teams and 12 women’s teams from across the world battle it out over three days to a full house of up to 40,000 spectators from 31 March to 2 April 2023.

Dettol x HK7s_pre-launch visual_resized.jpg

“At Reckitt, we seek out new opportunities to build shared success with our partners. It is our great honour to collaborate with the Hong Kong Rugby Union again to protect all fans attending the Hong Kong Sevens tournament so that everyone can fully enjoy the three-day event. With mass events returning to the city, the level of hygiene and health will remain a priority for many as the population has become accustomed to it.” said Boudewijn Feith, General Manager, Hong Kong/Taiwan at Reckitt.

“As one of the world’s most trusted disinfectant brands, Dettol will continue to protect everyone’s best moments with our expertise to help Hong Kongers safely embrace this new post-pandemic phase, that is free from masks and social distancing measures.”

Dettol will promote positive public hygiene practices and provide easy access to its widely trusted hygiene and disinfectant products throughout the tournament, keeping with Reckitt’s purpose of pursuing a healthier and cleaner world built on the foundation of good hygiene.

Safeguarding People’s Health with Dettol’s Trusted Products

Throughout this international rugby celebration, Dettol will provide onsite hygiene protection by placing Dettol hand sanitiser stations at 75 key locations across the Hong Kong Stadium, including concourse, entrances, security check zones and executive suites. This level of protection is important to ensure the safe and confident entrance into a new phase of hygiene behaviour at mass participation events. The deployment of Dettol’s sanitising stations will also help the spectators maintain good hygiene and stay healthy amid the cold and flu season.

“We are excited to welcome a full house of nearly 40,000 fans back at the Stadium as we bring the flagship event back in full swing this year. The crowd can enjoy every game to the fullest with all social distancing measures being lifted, and our partnership with Reckitt and Dettol is instrumental to the event’s success. We look forward to achieving another milestone together following our successful partnership last November,” said Bryan Rennie, General Manager of Commercial and Business Development of the Hong Kong Rugby Union.

Globally, Dettol has partnered with many leading organizations and supported major events worldwide, including the Birmingham 2022 Commonwealth Games, the English Football Association (FA), Cricket Australia, Hilton Hotels, British Airways, SF Express, Deliveroo, and Uber Taxi to deliver its brand purpose of protecting what people love.

Hashtag: #Reckitt #Dettol

The issuer is solely responsible for the content of this announcement.

About Reckitt:

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

Reckitt is the company behind some of the world’s most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

Every day, more than 30 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

We are a diverse global team of close to 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us, at

* Reckitt is the trading name of the Reckitt Benckiser group of companies

About Dettol
Dettol is a leader in germ protection helping families protect what they love for over 80 years through better hygiene. Founded in trust, efficacy and education, Dettol’s purpose is to ensure everyone has the right to good hygiene and, with its wide range of personal care and home care products, is continuing its fight to empower everyone with the knowledge to build positive and long-lasting hygiene habits.

For more information, please visit:

About HKRU
The Hong Kong Rugby Union (HKRU) was founded in 1952, and became an affiliated union of World Rugby in 1988. In 1968, the HKRU became a founding member of Asia Rugby and remains committed to the development of the game in Asia. In 2008, the HKRU presented the first neutral-venue Bledisloe Cup – followed by a second match in 2010. In 2013, the HKRU hosted the first British & Irish Lions match played in Asia and the following year hosted the first regional Olympic qualifier tournament for Rugby Sevens. The HKRU is a member of the Sports Federation & Olympic Committee of Hong Kong, China and provides competitive and social rugby opportunities for men and women at every age and skill level. For more information, please visit:

Best Mart 360 introduces China Merchants Hoi Tung as major shareholder, with the acquisition of 49% of the company’s shares at HK$1.76 per share

HONG KONG SAR – Media OutReach – 27 March 2023 – Best Mart 360 Holdings Limited (“Best Mart 360” or the “Company”, together with its subsidiaries, the “Group”; stock code: 2360.HK), a leisure food retailer in Hong Kong, announced that Mr. Lin Tsz Fung and Ms. Hui Ngai Fan entered into the Sale and Purchase Agreement (“S&P Agreement”) with China Merchants Hoi Tung Trading Company Limited (the “CMHT”), in relation to the sale and purchase of the Company’s Shares (“the Shares”). Pursuant to the S&P Agreement, China Merchants Hoi Tung Trading will purchase 490,000,000 Shares in aggregate, representing 49% of the total issued Shares. The total consideration for the sale shares is HK862,400,000, equivalent to HK1.76 per sale share.

Upon completion, Mr. Lin and Ms. Hui, through entities wholly owned by them, will each continue to hold their retained shares respectively, representing in aggregate 26% of the total issued shares.

CMHT is a wholly-owned subsidiary of China Merchants Group Limited and is a comprehensive trading company covering food, transportation, and commodity, with subsidiaries in 10 cities in China and 7 branches overseas.

Mr. Lin Tsz Fung, Chairman of the Group said, “We are honored to have CMHT as our major shareholder. With their extensive experience and expertise in the food and commodity sectors, along with their strong presence in China and internationally, will be invaluable in supporting our ongoing growth and development. We believe that this partnership will enable us to expand our global procurement efforts and further strengthen the brand of ‘Best Mart 360˚’ and ‘FoodVille’. ”

Mr. Zhou Song, CFO of China Merchants Group, extended congratulations and said, “Upon the completion of the project, we wish that both shareholders will fully leverage their strengths and work together to establish a stronger foothold in Hong Kong, while also focusing on the global market strategies to achieve mutual connectivity and access of resources and channels.”

Hashtag: #BestMart360

The issuer is solely responsible for the content of this announcement.

About Best Mart 360 Holdings Limited

Best Mart 360 Holdings Limited operates chain retail stores under the brand “Best Mart 360˚”, offering wide selection of imported and pre-packaged leisure foods and other grocery products principally from overseas. It is the Group’s business objective to offer “Best Quality” and “Best Price” products to customers through continuous efforts on global procurement with a mission to provide comfortable shopping environment and pleasurable shopping experience to customers. As at 30 September 2022, the Group operated a total of 144 chain retail stores, spanning strategic locations with heavy pedestrian flow in Hong Kong, Macau and Shenzhen. Among the chain retail stores, the global gourmet brand “FoodVille” launched in September 2021 is also included, targeting the medium-to-high-end-market.

Uni-Bio Science Group Limited Announces 2022 Annual Results

Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved
Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships

HONG KONG SAR – EQS Newswire – 27 March 2023 – A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries referred to as the “Group”, stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2022 (the “Year”).

Key Accomplishments in 2022

During the Year, the Group achieved a spectrum of accomplishments, for both of its marketed products and innovative biologics. The key highlights include:

  1. During the Year, the Group achieved a record high turnover of HK$440.3 million, representing a noticeable increase of 24.6% year-on-year (“YoY”). Sales of Pinup® and Boshutai® performed exceptionally well, registering an increase of 51.2% and 292.5% YoY respectively.
  2. The Group made a remarkable turnaround, posting a profit of HK$38.5 million with a significant increase of 296.6% YoY, marking an important milestone for a research-oriented biopharmaceutical company.
  3. The Group’s Acarbose Tablets (Boshutai®) was successfully awarded the drug alliance procurement bid for the second and fourth batches of medicines for two years in the 13-provinces Alliance Procurement. To meet the growing demand for Boshutai®, the Group had already expanded its production capacity at its strategic partner’s Suzhou production site to ensure supply stability.
  4. New Drug Application (“NDA”) of the Group’s Bogutai® (teriparatide injection) had been accepted by the China National Medical Products Administration (“NMPA”) and completed the China Center for Food and Drug Inspections (“CFDI”) registration site verification. Bogutai® will be the Group’s fifth marketed drug and the first domestically manufactured PTH Liquid in China to use a disposable injection pen.
  5. The Group has continuously improved EGF process technology and increased the production capacity of the drug substance to 4 times the original amount, further enhancing production efficiency, reducing costs, while opening up new formulation opportunities.
  6. The formulation development of oral form Uni-GLP-1 was completed, and the results showed that its bioavailability was superior to the positive control oral semaglutide. Currently, formal animal studies in beagle dogs are under preparation to further validate the bioavailability and pharmacokinetics of the oral form Uni-GLP-1 in animals. The clinical work of Uni-GLP-1 injection pen is on schedule for related pharmacological studies.
  7. The Group’s fibronectin products are shown to be as effective as natural fibronectin derived from human blood. During the Year, the Group had completed the development of fibronectin raw material, which have high yield and high activity. It will be the first advanced skincare raw material of the Group to be launched.

Annual Results

In 2022, the Group recorded a record-breaking revenue of approximately HK$440.3 million, representing a significant increase of 24.6% year-on-year (2021: HK$353.4 million). The increase in revenue was mainly attributable to the impressive sales growth of Pinup® and Boshutai®. Pinup® saw a remarkable increase of 51.2% in revenue, jumping from approximately HK$142.2 million to approximately HK$215.1 million for the Year. The increase was attributable to Pinup®’s inclusion in the national centralized procurement in 2021, which has secured the Group with substantial hospital orders. During the Year, revenue of Boshutai® increased substantially from approximately HK$4.5 million to approximately HK$17.4 million, representing a significant increase of 292.5%. GeneSoft® recorded an increase in revenue from approximately HK$36.3 million to approximately HK$38.4 million, representing an increase of 6.0%. Revenue generated from GeneTime® was approximately HK$169.4 million, representing a decrease of 0.6% from approximately HK$170.5 million in 2021. Despite the pandemic-related production interruptions in the first quarter of 2022, the Group quickly resumed and upgraded production of GeneTime®. As a result, sales of GeneTime® resumed growth in the second half of the Year, offsetting the earlier shortfall.

Gross profit was approximately HK$334.9 million, representing an increase of 20.9% as compared with approximately HK$277.0 million in 2021, whereas gross profit margin was 76.1% (2021: 78.4%). Thanks to the Group’s diligent internal control, general and administrative expenses accounted for merely 10.7% of revenue in 2022 as compared with 13.3% in 2021. The selling and distribution expense for the Year also decreased to 48.0% of revenue from 52.5% in 2021. The R&D expenses decreased by 28.8% to approximately HK$35.8 million due to the completion of several clinical tests and the capitalization of development expenses.

The Group’s commitment to cost control and profitability resulted in earnings before interest, tax, depreciation and amortization (“EBITDA”) for the Year of HK$65.8 million as compared to HK$13.7 million in 2021. Net cash flow of HK$48.7 million from operating activities for the Year was recorded, representing the second consecutive year of positive cash flow for the Group. The Group recorded a profit of approximately HK$38.5 million for the Year, a remarkable increase of 296.6% year-on-year (2021: loss of HK$19.6 million). Basic earnings per share was approximately HK$0.61 cents (2021 basic loss per share HK$0.31 cents).

Prospects

Despite the reopening of borders, global economic headwinds are expected to continue in 2023 due to rising interest rates, inflation, and geopolitical trends. These factors will create economic shifts and challenges for businesses in areas such as trade, investment, and labor. Yet, with the implementation of the “Healthy China” strategy and the support of favorable factors such as supportive policies, industry efforts, and capital investments, the pharmaceutical and healthcare sector is expected to remain one of the most dynamic and promising fields in China over the longer term.

Despite the unpredictable headwinds, the Group has consistently maintained a healthy financial position with a positive cash flow and a manageable debt load. Our innovative “four-wheel drive” business model, which includes high-value generic drugs, bio-innovative drugs, new skincare raw materials, and CMO business, enables us to diversify our income streams and adapt to changing market conditions. This approach fosters sustainable growth while positioning us as a leader in the competitive biopharmaceutical landscape.

Looking forward, Mr. Kingsley Leung, Chairman of Uni-Bio Science said, “We are well-equipped to navigate challenges and capitalize on emerging opportunities, remaining dedicated to product innovations. We have enhanced production capacity four-fold to meet the growing demand of our signature EGF products. We have also been exploring different applications of the EGF products while developing different dosage forms of the EGF products, such as gel form, film form, and VSD foam dressings. The single-dose form of GeneSoft® (no preservatives) utilizing the Blowing Filling and Sealing packaging technology has also been under development, which can reduce the risk of cross-infection as well as is safer and more convenient to use. This technology will also be used to develop Diquafosol Sodium Eye Drops, which is complementary to GeneSoft®.

Besides product innovation, our product development has also come to fruition. Bogutai®, the first domestically manufacturing PTH Liquid in China to use a disposable injection pen, will be approved for product launch by September 2023. It will become our fifth marketed and self-developed drug. We believe that Bogutai® will become another signature product. Meanwhile, our first advanced raw skincare material, fibronectin, is also ready for market launch in 2023. We believe with these products will further diversify our revenue stream and will ride on the growing market opportunities. At the same time, we have been preparing for the new round of national centralized procurement for Pinup®, which will be launched as soon as in April 2023. As Pinup® was among the first to be selected in the fourth batch of the national centralized procurement, the Group will enjoy the advantage and is confident to be selected in the upcoming procurement.

Uni-Bio is steadfast in its efforts to strengthen its comprehensive R&D capabilities and broaden its portfolio of best-in-class products. We have been partnering with Alephoson Biopharmaceuticals Ltd. and DotBio Pte. Ltd. to investigate the potential application of Cell Penetration Protein Alternation Technology (CePPA) and co-develop next-generation best-in-class compounds in ophthalmology and other potential therapeutic areas since late 2021. We have also committed to the research of innovative delivery technology for oral drugs of peptide drugs to solve many pain points caused by traditional single drug delivery. Some of which under development include 3rd generation oral form of Uni-PTH, oral dosage form of Uni-GLP-1, as well as Uni-GLP-1 injection pen. Through these efforts, we aim to further diversify the formulation choices of the Group’s marketed and future products, providing better solutions that meet the evolving needs of patients.”

The issuer is solely responsible for the content of this announcement.

About Uni-Bio Science Group Limited

Uni-Bio Science Group Limited is principally engaged in the research and development, manufacture and distribution of pharmaceutical products. The research and development centre is fully equipped with a complete system for the development of genetically-engineered products with a pilot plant test base which is in line with NMPA requirements. The Group also has two GMP manufacturing bases in Beijing and Shenzhen. The Group also has a highly efficient commercialization platform and marketing network. The Group focuses on the development of novel treatments and innovative drugs addressing the therapeutic areas of endocrine such as diabetes and osteoporosis, ophthalmology and dermatology.

Uni-Bio Science Group Limited was listed on the Main Board of the Hong Kong Stock Exchange on November 12, 2001. Stock code: 0690.

Rain Forecast Across Laos Could Wash Away Pollution

The weather bureau has forecast rain across Laos from today, with strong winds and thunderstorms set to wash away air pollution.

14th Lao Business Forum Sees 400 Local and International Participants

14th Lao Business Forum Sees 400 Local and International Participants
Prime Minister Sonexay Siphandone speaking at the 14th Annual Lao Business Forum.

The 14th annual Lao Business Forum, held on 27 March 2023, took place in Vientiane to review the progress of public-private dialogue aimed at improving the business environment in Laos.